STAT - Reporting from the frontiers of health and medicine

Health

Health Tech

First Opinion

By Adam Hayden

Opinions+ Stifling biopharma mergers would kill the innovation economy that generates new therapies
First Opinion A close brush with gun violence made me think about how to confront an epidemic during a pandemic
Health What Delta has changed in the Covid pandemic — and what it hasn’t
Health Retired neurologist with Alzheimer’s knows firsthand the risks of Aduhelm
Exclusive FDA, under pressure, plans ‘sprint’ to accelerate review of Pfizer’s Covid-19 vaccine for full approval

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

FDA threatens to fine another drug maker for failing to report clinical trial results
Up and down the ladder: The latest comings and goings
Lawmakers ask Defense Department about using a controversial maneuver to lower drug prices

Exclusive

Health

Heavyweights

Health

Prescription Politics

Special Report

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Health For many, the belated realization that Covid will be ‘a long war’ sparks anger and denial
Health What Delta has changed in the Covid pandemic — and what it hasn’t
Exclusive FDA, under pressure, plans ‘sprint’ to accelerate review of Pfizer’s Covid-19 vaccine for full approval
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health The Covid-19 Tracker
Health How the Covid pandemic ends: Scientists look to the past to see the future
Health Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months, data show